Skip to main content

Most Popular

COVID-19 Vaccination - Phase Ib Begins

Jan 04, 2021

The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines. 

Read Article

Update on Polymyalgia Rheumatica and Giant Cell Arteritis (Best of 2020)

Dec 31, 2020

Editor's note: This article originally appeared August 24, 2020, and is being shared again as part of RheumNow's "Best of 2020".

Read Article

2020 Rheumatology Year in Review

Jan 14, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.

Read Article

Rheumatologists Rank 2nd in Physician Burnout

Jan 26, 2021

The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine.

Read Article

RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)

Jan 15, 2021

Dr. Jack Cush reviews the news and journal reports from the past week on How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...

Read Article

Travel During COVID-19 Pandemic

Jan 18, 2021

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article

ACR 2020 Reproductive Guidelines - Medication Use with Pregnancy (Best of 2020)

Dec 30, 2020

Editor's note: This article originally appeared September 9, 2020, and is being shared again as part of RheumNow's "Best of 2020". We hope you enjoy reading it again. 

Read Article

Best of 2020: New EULAR/ACR Classification Criteria for SLE

Dec 29, 2020

Editor's note: this article originally appeared in August and is being shared again as part of RheumNow's "Best of 2020". 

Read Article

ProDERM Study: IVIG in Dermatomyositis

Jan 13, 2021

The ProDERM study design and outcomes are previewed in Medicine; and as promised the results were revealed at ACR Convergence in November 2020 showing that IVIg is safe, effective and superior to placebo i(PBO) in patients with dermatomyositis (DM).

Read Article

RheumNow Podcast – Don’t Hold the Benlysta, Take the Vaccine (1.22.2021)

Jan 22, 2021

Dr. Jack Cush reviews the news and journal articles from the past week on, with more than a dozen items to review on this week's podcast.

Read Article

JAK Inhibitor Misses Endpoint in Safety Study. Now What?

MedPage Today
Jan 27, 2021

Pfizer announced results Wednesday from its FDA-mandated postmarketing safety study of tofacitinib (Xeljanz), and they don't bode well for the drug and possibly others in its class.

Read Article

Adipose Transplants as a New Regulator of Osteoarthritis

Jan 11, 2021

A novel report from PNAS suggests that in osteoarthritis (OA), the damage is not entirely from body weight and mechanics, instead it may be from adipose tissue itself.

Read Article

Voclosporin FDA Approved for Lupus Nephritis

Jan 24, 2021

On January 22nd, the FDA approved voclosporin (Lupkynis) for use in adults with active lupus nephritis; voclosporin is a calcineurin-inhibitor immunosuppressant indicated for use in combination with a background immunosuppressive therapy.

Read Article

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Jan 08, 2021

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on

Read Article

Factors Predictive of SLE Flare After HCQ Taper/Discontinuation

MedPage Today
Jan 19, 2021

The benefits of hydroxychloroquine in lupus are many, but if you were to withdraw HCQ?

Read Article

Adherence to Hydroxychloroquine Lowers Lupus Mortality

Jan 07, 2021

A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality. 

Read Article

Long Term Safety and Efficacy of Tacrolimus in Lupus Nephritis

Jan 13, 2021

Takeuchi et al has published their large experience with long-term tacrolimus use in lupus nephritis patients showing its real-world safety and efficacy.

Read Article

Zoomatology – Present in Absentia

Jan 06, 2021

Zoom has become the slam dunk answer to the pandemic. With zoom you can avoid congregations, but still attend and belong.  Because of zoom you can sustain your business and continue medical care.  With zoom, learning moved from the classroom to the dining room for all.

Read Article

20,21 Whatever it Takes

Jan 05, 2021

Amazingly, we made it through 2020, a most forgettable year.

Life was great in the first 3 months of 2020, and then COVID hit the fan and a pandemic steamroller derailed life as we knew it.

Read Article

Protective Effects of Colchicine in Non-Hospitalized COVID-19

Jan 25, 2021

A press release from the Montreal Heart Institute has announced that the COLCORONA clinical trial has provided evidence of the protective effect of colchicine; demonstrating a 21% reduced risk of death or hospitalizations in patients with COVID-19 compared to placebo. 

Read Article